FinanceAUSTIN, Texas, Dec 11 /PRNewswire FirstCall/ Introgen Therapeutics, Inc Investor RelationsAUSTIN, Texas, July 28 /PRNewswire FirstCall/ Introgen Therapeutics, Inc :: Introgen Therapeutics Pursues Dual Listing on London Stock Exchangeannounced today that its management has been authorized to take steps to effect AUSTIN, Texas, June 6 /PRNewswire FirstCall/ Introgen Therapeutics, Inc sev prnewswire com/biotechnology/20050605/NYM12306062005 1 html More pages from news medical net Introgen Reports Advances in Oncolytic Virus Program Health RedOrbitAUSTIN, Texas, Feb 24 /PRNewswire FirstCall/ Introgen Therapeutics, Inc :: Introgen Therapeutics Inc Board of Regents owns stock in Introgen Introgen has now analyzed additional head and neck cancer patients for the treatment of www news medical net Introgen Reports Advances in Oncolytic Virus Program Health RedOrbitAUSTIN, Texas, Feb 24 /PRNewswire FirstCall/ Introgen Therapeutics, Inc sev prnewswire com/biotechnology/20050605/NYM12306062005 1 html More pages from drugnewswire com Introgen Therapeutics, Inc Introgen has now analyzed additional head and neck cancer patients for the Introgen believes the ADVEXIN biomarker results www medicalnewstoday com/medicalnews php?newsid=58668&nfid=rssfeeds More pages from corporate ir net Introgen Therapeutics, Inc Introgen currently has two ongoing phase 3 studies of www business com/directory/pharmaceuticals_and_biotechnolo ntrogen_therapeutics,_inc More pages from fool com Introgen licenses nanoparticle patents Boston comBiopharmaceutical company Introgen Therapeutics Inc Board of Regents owns stock in Introgen Introgen is developing molecular therapeutics, immunotherapies, vaccines and Introgen maintains integrated research, development, manufacturing, clinical and biz yahoo com Introgen Therapeutics Announces Key Regulatory Advance For ADVEXIN ProgramIntrogen Therapeutics, Inc Introgen is developing FinanceAUSTIN, Texas, Dec 12 /PRNewswire FirstCall/ Introgen Therapeutics, Inc products and technologies of strategic interest to both SR Pharma and Introgen maintains integrated research, development, manufacturing, clinical and biz yahoo com Introgen's gene drug demonstrates tumor growth controlFor the first time in humans cells, preclinical studies show the MDA 7 protein Houston and Austin, TX, October 25, 2001 Introgen Therapeutics, Inc Introgen is developing molecular therapeutics, immunotherapies, vaccines and Introgen www corporate ir net/ireye/ir_site zhtml?ticker=ingn&scrip 1&layout=7&item_id=736218 More pages from boston com Broad European Patent Issued for Introgen's Nanoparticle Drug Delivery System; Claims Cover Forty Tumor Suppressors FirstCall/ A patent licensed exclusively to Introgen Therapeutics, Inc Introgen is developing molecular therapeutics, immunotherapies, vaccines and www stockhouse com/news/news asp?newsid=4842195&tick=INGN More pages from drugnewswire com Introgen Therapeutics NewsIntrogen Therapeutics News continually updated from thousands of sources around the net Introgen Reports that INGN 241 in Combination with Avastin Results www topix net/com/ingn More pages from topix net INGN Introgen Therapeutics, Inc Investor RelationsAUSTIN, Texas, July 28 /PRNewswire FirstCall/ Introgen Therapeutics, Inc Investor RelationsAUSTIN, Texas, July 28 /PRNewswire FirstCall/ Introgen Therapeutics, Inc Announces FinancingAUSTIN Texas November 7 /PRNewswire Introgen anticipates using the net Introgen Reports that INGN 241 in Combination with Avastin Results www topix net/com/ingn More pages from boston com Broad European Patent Issued for Introgen's Nanoparticle Drug Delivery System; Claims Cover Forty Tumor Suppressors FirstCall/ A patent licensed exclusively to Introgen Therapeutics, Inc Introgen INGN 234 1/2 www 39kf com/yyjj/gc/2005 11 06 115259 shtml More pages from finance google com/finance?q=INGN More pages from redorbit com Introgen Announces Conference Call: Financial News Yahoo! FinanceGet detailed information on INTROGEN THERAPEU (INGN) including quote performance, Introgen Reports that INGN 241 in Combination with Avastin Results www topix net/com/ingn More pages from biz yahoo com Introgen's gene drug demonstrates tumor growth controlFor the first time in humans cells, preclinical studies show the MDA 7 protein Houston and Austin, TX, October 25, 2001 Introgen Therapeutics, Inc Google FinanceUPDATE 1 Introgen says experimental cancer drug gets fast tracked and sends the stock soaring To a cash burning biotech like Introgen, which only has $26 million in the bank www fool com/investing/general/2003/09/19/introgen rockets on trials aspx More pages from today reuters com/news/articleinvesting aspx?view=PR&symbo ID=194262+11 Dec 2006+PRN More pages from finance yahoo com Introgen Therapeutics Announces Key Regulatory Advance For ADVEXIN ProgramIntrogen Therapeutics, Inc Introgen Therapeutics' lead product, finance yahoo com/q?s=INGN More pages from drugnewswire com Introgen Therapeutics NewsIntrogen Therapeutics News continually updated from thousands of sources around the net Introgen Reports that INGN 241 in Combination with Avastin Results www topix net/com/ingn More pages from biz yahoo com Introgen's gene drug demonstrates tumor growth controlFor the first time in humans cells, preclinical studies show the MDA 7 protein Houston and Austin, TX, October 25, 2001 Introgen Therapeutics, Inc Introgen is developing molecular therapeutics, Novel, Minimally Toxic Powered by Dot Command Center, Inc © Copyright 2007 Introgen Therapeutics, Inc Investor RelationsAUSTIN, Texas, July 28 /PRNewswire FirstCall/ Introgen Therapeutics, Inc Introgen is developing molecular therapeutics, immunotherapies, vaccines and biz yahoo com Introgen's gene drug demonstrates tumor growth controlFor the first time in humans cells, preclinical studies show the MDA 7 protein Houston and Austin, TX, October 25, 2001 Introgen Therapeutics, Inc www eurekalert org/pub_releases/2001 10/pn igd102501 php More pages from redorbit com Introgen Announces Conference Call: Financial News Yahoo! FinanceGet detailed information on INTROGEN THERAPEU Yahoo! v=81 More pages from today reuters com/news/articleinvesting aspx?view=PR&symbo ID=194262+11 Dec 2006+PRN More pages from stockhouse com Introgen Announces New Clinical Data Confirming ADVEXIN(R) Survival BenefitAUSTIN, Texas, Dec 12 /PRNewswire FirstCall/ Introgen Therapeutics, Inc Introgen has now analyzed additional head and neck cancer patients for the www redorbit com/news/health/405533/introgen_reports_advan ndex html?source=r_health More pages from boston com Broad European Patent Issued for Introgen's Nanoparticle Drug Delivery System; Claims Cover Forty Tumor Suppressors FirstCall/ A patent licensed exclusively to Introgen has now analyzed additional head and neck cancer patients for the www redorbit com/news/health/763254/introgen_announces_new ndex html?source=r_health More pages from drugnewswire com Introgen Therapeutics, Inc Introgen is developing molecular therapeutics, immunotherapies, vaccines and Introgen www corporate ir net INGN: Summary for INTROGEN THERAPEU Yahoo!